Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Series A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
31,278,271
-
Total 13F shares
-
14,445,035
-
Share change
-
-767,517
-
Total reported value
-
$76,117,702
-
Price per share
-
$5.42
-
Number of holders
-
51
-
Value change
-
-$8,913,863
-
Number of buys
-
27
-
Number of sells
-
16
Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) as of Q4 2023
As of 31 Dec 2023,
Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,445,035 shares.
The largest 10 holders included
NEA Management Company, LLC, FMR LLC, BAKER BROS. ADVISORS LP, HHLR ADVISORS, LTD., Artal Group S.A., Rock Springs Capital Management LP, PFM Health Sciences, LP, Alyeska Investment Group, L.P., Altium Capital Management LP, and BlackRock Inc..
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.